Related Experiment Video

Updated: Jan 21, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

355

Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges

A Pavan1,2, I Attili1,2, G Pasello1

  • 1Medical Oncology 2, Istituto Oncologico Veneto IOV IRCCS, Via Gattamelata 64, 35100, Padova, Italia.

Journal for Immunotherapy of Cancer
|August 7, 2019
PubMed

Insights

Small cell lung cancer (SCLC) treatment is evolving with immunotherapy. Understanding molecular pathways is key to overcoming resistance and improving outcomes for SCLC patients.

Area of Science:

  • Oncology
  • Immunotherapy
  • Molecular Biology

Background:

  • Small cell lung cancer (SCLC) management has seen limited progress for decades.
  • Recent discoveries reveal DNA repair and molecular pathway alterations in SCLC.
  • Preclinical data suggest targeting these pathways may offer new therapeutic avenues.

Purpose of the Study:

  • To review current clinical evidence on immunotherapy in SCLC.
  • To describe molecular mechanisms of treatment resistance in SCLC.
  • To discuss potential therapeutic combinations involving immune checkpoint inhibitors (ICIs).

Main Methods:

  • Literature review of clinical trials and preclinical studies on SCLC immunotherapy.
  • Analysis of molecular pathways implicated in SCLC growth and resistance.
  • Discussion of rational therapeutic combinations, particularly with ICIs.

Main Results:

  • Immune checkpoint inhibitors (ICIs) show promise in SCLC, though challenges remain.
  • Identifying predictive markers for ICI response is crucial.
  • Understanding molecular drivers of resistance is essential for combination strategies.

Conclusions:

  • Immunotherapy, particularly ICIs, represents a promising frontier in SCLC treatment.
  • Overcoming treatment resistance requires a deeper understanding of SCLC molecular biology.
  • Rational combination therapies are needed to improve clinical outcomes in SCLC.
Keywords:
Combination therapyEnhancer of zeste homolog 2Immune checkpoint inhibitorsImmunotherapySmall cell lung cancerTumor microenvironment

More Related Videos

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

11.0K
Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

7.5K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.1K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.9K
Molecular Models02:00

Molecular Models

Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.6K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K
Molecular Orbital Theory II03:51

Molecular Orbital Theory II

Molecular Orbital Energy Diagrams
27.0K